Inhalation is the most prevalent route of human exposure to insoluble pentavalent vanadium(V) oxides and soluble salts in urban/occupational settings. While initial pulmonary clearance of both soluble and insoluble forms of V is fairly rapid, complete clearance/degree of absorption of any V agent is ultimately a function of its solubility. Nevertheless, there are still several general toxicologic outcomes that arise from lung deposition of various V agents (as pure compounds or Vcontaminated dusts). Workers exposed to V-bearing dusts or fumes display an increased incidence of several lung diseases (e.g., asthma, bronchitis, pneumonia). Similarly, after deposi tion of urban particulate matter (PM) or residual oil fly ash (ROFA), animals develop states of immunomodulation (inflammation, neutrophilic alveolitis, modified resistance to infection) that correlate with the levels of V in the particles. This presentation focused on how general (and in some cases agent-specific) mechanisms have been formulated to explain how entrained V agents induce toxicity and immunomodula tion in the lungs.